Related Experiment Video

Updated: Aug 25, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

[Growth hormone in preterm and intrauterine growth retarded infants]

M Walczak, E Korman

    Endokrynologia, Diabetologia I Choroby Przemiany Materii Wieku Rozwojowego : Organ Polskiego Towarzystwa Endokrynologow Dzieciecych
    |June 24, 2003
    PubMed

    Insights

    This study examines elevated somatotropinemia (growth hormone) in fetuses, neonates, and infants. It explores potential reasons for higher growth hormone levels, especially in preterm and intrauterine growth retarded infants.

    Area of Science:

    • Endocrinology
    • Neonatology
    • Pediatric Growth

    Context:

    • Somatotropinemia, or elevated growth hormone levels, is observed in fetal and infant populations.
    • Preterm and intrauterine growth retarded (IUGR) infants exhibit particularly high growth hormone levels.

    Purpose:

    • To present data on somatotropinemia in fetuses, neonates, and infants.
    • To discuss hypotheses explaining elevated growth hormone levels in these pediatric groups.

    Summary:

    • Data indicate higher somatotropinemia in fetuses, neonates, and infants.
    • Hypotheses are explored for elevated growth hormone, focusing on preterm and IUGR infants.

    Impact:

    • Provides insights into growth hormone regulation in early development.
    • Contributes to understanding growth disturbances in high-risk infant populations.

    More Related Videos

    Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays11:17

    Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

    Published on: January 7, 2016

    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

    Published on: February 15, 2018

    Related Concept Videos

    Nature and Nurture01:10

    Nature and Nurture

    Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
    Insulin: Dosing Regimen and Adverse Effects01:16

    Insulin: Dosing Regimen and Adverse Effects

    Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
    The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
    Hypoglycemia and Glucagon01:15

    Hypoglycemia and Glucagon

    Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...